Evonik (EVK GY) confirms a receipt of a non-binding approach from BASF (BAS GY) regarding a potential takeover offer, but no talks taken place

A confirmed non-binding approach with no talks yet held sits at the earliest, least committed end of the M&A sequence; the standard pattern is that the target's confirmation, often prompted by press speculation or disclosure rules, precedes any formal process, and a large share of such approaches never reach a firm offer. The spread mechanics at this stage are well established: the target trades up toward an implied but unconfirmed price while the acquirer typically softens on dilution, synergy and leverage questions, with the gap between the target's price and any speculated offer level expressing the market's read on completion probability. Between two German chemicals majors, antitrust and works-council politics are material variables, and combinations in this sector have historically drawn extended regulatory scrutiny on overlapping product lines, which stretches timelines and widens the range of outcomes. BASF's prior form matters here: large acquisitive moves by the company have been episodic rather than serial, so the strategic rationale, whether portfolio consolidation or opportunistic valuation, will be the first question analysts put to management. Worth watching next is whether a firm intention announcement follows, any statement on price or structure, and the reaction of the target's largest shareholders, whose posture has often decided these situations before regulators do.